DRUG-TREATMENT OF ALLERGIC CONJUNCTIVITIS - A REVIEW OF THE EVIDENCE

被引:51
作者
CIPRANDI, G
BUSCAGLIA, S
CERQUETI, PM
CANONICA, GW
机构
[1] UNIV GENOA,DIMI,DEPT INTERNAL MED,ALLERGY & CLIN IMMUNOL SERV,I-16132 GENOA,ITALY
[2] UNIV GENOA,OCULIST CLIN,I-16126 GENOA,ITALY
关键词
D O I
10.2165/00003495-199243020-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Allergic conjunctivitis, unlike several other ocular diseases, is seldom followed by permanent visual impairment: nevertheless, it is important because of both its frequency and its severity. Two major forms, seasonal and perennial, are considered in this review. To recognise the hallmarks of allergic conjunctivitis, clinicians have need of a thorough knowledge of its pathophysiological aspects and clinical features, enabling them to choose the best and most suitable therapy among the alternatives. The aims of treatment vary according to the symptoms, severity and characteristics of the allergic reactions; in general, treatment is based mainly on environmental control, pharmacotherapy and (sometimes) specific immunotherapy. Topical vasoconstrictors, decongestant compounds, standard antihistamines or combinations of these drugs have been used for a number of years to treat the acute and/or persistent symptomatology, and in order to prevent the side effects of a prolonged treatment with topical glucocorticosteroids. Nevertheless, the latter represent the most powerful anti-inflammatory drugs, and are particularly recommended in short term treatment (5 to 7 days) in severe acute symptomatology. Orally administered 'classic' antihistamines, i.e. histamine H-1-receptor antagonists, are effective and very convenient in either short or long term treatment, largely because the new compounds also act on the inflammatory process secondary to the allergic events. Recently, other topical compounds such as sodium cromoglycate (cromolyn sodium), nedocromil and nonsteroidal anti-inflammatory drugs (NSAIDs) [i.e. piroxicam, aspirin] have become available. Sodium cromoglycate and nedocromil act as prophylactic compounds, able to prevent the allergic reaction; NSAIDs represent a valid and effective alternative to glucocorticosteroids in several situations.
引用
收藏
页码:154 / 176
页数:23
相关论文
共 175 条
  • [31] EVALUATION OF COMBINED H-1-RECEPTOR AND H-2-RECEPTOR BLOCKING-AGENTS IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS
    CARPENTER, GB
    BUNKERSOLER, AL
    NELSON, HS
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 71 (04) : 412 - 417
  • [32] CERQUETI P M, 1987, Bollettino di Oculistica, V66, P179
  • [33] CHIN GN, 1978, J PEDIAT OPHTH STRAB, V15, P326, DOI 10.3928/0191-3913-19780901-17
  • [34] KETOTIFEN INHIBITS THE CUTANEOUS BUT NOT THE AIRWAY RESPONSES TO PLATELET-ACTIVATING FACTOR IN MAN
    CHUNG, KF
    MINETTE, P
    MCCUSKER, M
    BARNES, PJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (06) : 1192 - 1198
  • [35] NONSTEROIDAL TREATMENT OF POLLEN-INDUCED CONJUNCTIVITIS - COMPARISON OF DIFFERENT PHARMACOLOGICAL PROTOCOLS
    CIPRANDI, G
    CERQUETI, PM
    SACCA, S
    CIURLO, G
    TOSCA, MA
    CANONICA, GW
    [J]. ALLERGY, 1991, 46 (05) : 393 - 395
  • [36] CIPRANDI G, 1990, ANN ALLERGY, V65, P156
  • [37] CIPRANDI G, 1990, Clinical and Experimental Allergy, V20, P55
  • [38] LORATADINE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY
    CLISSOLD, SP
    SORKIN, EM
    GOA, KL
    [J]. DRUGS, 1989, 37 (01) : 42 - 57
  • [39] THE EFFECT OF NEDOCROMIL SODIUM ON NASAL PROVOCATION WITH ALLERGEN
    CORRADO, OJ
    GOMEZ, E
    BALDWIN, DL
    CLAGUE, JE
    DAVIES, RJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (02) : 218 - 222